Johnsen, H E, Haioun, C, Lugtenburg, P J, Salar, A, Jaeger, U, Pettengell, R, Rossi, F G, Verhoef, G, Schwenkglenks, M, Bendall, K & Duehrsen, U 2012, ' Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice ', Leukemia and Lymphoma, vol. 53, no. 5, pp. 982-4 . https://doi.org/10.3109/10428194.2011.643407
Pettengell, R, Johnsen, H E, Lugtenburg, P J, Silvestre, A S, Dührsen, U, Rossi, F G, Schwenkglenks, M, Bendall, K, Szabo, Z & Jaeger, U 2013, ' Erratum to: Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma ', Supportive Care in Cancer, vol. 21, no. 2, pp. 653 . https://doi.org/10.1007/s00520-012-1678-2 Supportive Care in Cancer
Salar, A, Haioun, C, Rossi, F G, Duehrsen, U, Pettengell, R, Johnsen, H E, Jaeger, U, Verhoef, G, Schwenkglenks, M, Bacon, P, Bendall, K & Lugtenburg, P J 2012, ' The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21 : Findings from clinical practice ', Acute Myeloid Leukemia Research Today, vol. 36, no. 5, pp. 548-53 . https://doi.org/10.1016/j.leukres.2012.02.002